Zambia

Reimbursed Care Access

Psychedelic and classic entheogenic compounds in Zambia are overwhelmingly controlled under national narcotics/controlled-substances legislation; most (psilocybin, MDMA, DMT, 5-MeO‑DMT, ibogaine, mescaline, 2C‑X, ayahuasca preparations) have no authorised medical use outside approved research. Ketamine is an authorised and listed anaesthetic in Zambia’s essential medicines lists and is used in public and private hospitals; specialised pharmaceutical products derived from ketamine (esketamine/Spravato) are not registered or reimbursed in Zambia.